Vontobel Holding
MCRB icon

Vontobel Holding’s Seres Therapeutics MCRB Stock Holding History

Vontobel Holding’s Portfolio MCRB Stock Details MCRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$970K Sell
122,975
-15,493
-11% -$118K ﹤0.01% 827
2026
Q1 		$1.23M Buy
138,468
+35,234
+34% +$413K ﹤0.01% 613
2025
Q4 		$1.54M Buy
103,234
+4,723
+5% +$82.4K ﹤0.01% 644
2025
Q3 		$1.9M Buy
98,511
+18,186
+23% +$290K 0.01% 567
2025
Q2 		$892K Buy
80,325
+26,027
+48% +$229K ﹤0.01% 716
2025
Q1 		$760K Buy
54,298
+7,383
+16% +$116K ﹤0.01% 665
2024
Q4 		$780K Buy
46,915
+27,174
+138% +$442K ﹤0.01% 663
2024
Q3 		$374K Buy
+19,741
New +$400K ﹤0.01% 866
2024
Q2 		– Sell
-850
Closed -$13.2K – 1125
2024
Q1 		$13.2K Hold
850
– – ﹤0.01% 1080
2023
Q4 		$23.8K Hold
850
– – ﹤0.01% 1085
2023
Q3 		$40.5K Sell
850
-943
-53% -$72K ﹤0.01% 1047
2023
Q2 		$172K Buy
1,793
+766
+75% +$83.4K ﹤0.01% 1022
2023
Q1 		$116K Buy
+1,027
New +$111K ﹤0.01% 1021
2021
Q3 		– Sell
-689
Closed -$329K – 1201
2021
Q2 		$329K Buy
+689
New +$291K ﹤0.01% 886

Other funds holding MCRB

FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vontobel Holding's MCRB Position: Q2 2026 in Review

Vontobel Holding reduced its Seres Therapeutics (MCRB) stake by 11% in Q2 2026, selling an estimated $118K and leaving 122,975 shares worth $970K. The position accounts for ﹤0.01% of the portfolio, ranked #827.

Vontobel Holding first reported a position in MCRB in Q2 2021 and has held it in 14 quarters since. The position peaked at $1.9M in Q3 2025. 36 funds tracked by Wall St. Rank hold MCRB as of Q2 2026.

  • Vontobel Holding held 122,975 shares of Seres Therapeutics worth $970K as of Q2 2026.
  • Vontobel Holding sold 15,493 Seres Therapeutics shares in Q2 2026, an estimated $118K.
  • Seres Therapeutics made up ﹤0.01% of Vontobel Holding's portfolio in Q2 2026, its #827 holding.
  • Vontobel Holding first reported a position in Seres Therapeutics in Q2 2021 and has held it in 14 quarters since.
  • Vontobel Holding's Seres Therapeutics position peaked at $1.9M in Q3 2025.
  • 36 funds tracked by Wall St. Rank held Seres Therapeutics as of Q2 2026.

Based on Vontobel Holding's 13F filing for Q2 2026, filed 3 Aug 2026.